GP100 Intron 4 Peptide (VYFFLPDHL)
gp100/pmel, also known as pmel17, is a melanoma-associated differentiation antigen that is investigated as a target in melanoma immunotherapy.
| RP30964 | |
|
|
|
| ¥10,000.00 | |
|
|
|
|
|
|
| Ask us a question | |







































